フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation PR Newswire PHILADELPHIA, June 13, 2017...
New Study Shows IO Loop™ Improves Patient Follow-up, Engagement and Satisfaction Following Treatment With TheraSphere® PR Newswire LONDON, June...
SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research Programme PR Newswire WASHINGTON, June 7, 2017 WASHINGTON, June...
BTG and HealthLoop Collaborate on IO Loop™, an Exclusive Service to Connect Patients and Interventional Oncologists Throughout Treatment PR...
First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads PR Newswire LONDON, April 20, 2017 LONDON, April 20, 2017...
BTG Announces CE Mark Certification for DC Bead LUMI™, the First Commercially Available Radiopaque Drug-Eluting Bead in the EU PR...
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology PR Newswire LONDON, February 15...
PneumRx® Coils Included in New Global Clinical Guidelines and Given Positive Recommendation to Treat Severe Emphysema Patients in France PR...
First Patient in Malaysia Receives TheraSphere™ radioembolisation Therapy PR Newswire LONDON, October 19, 2016 LONDON, October 19, 2016...
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y™ Dosimetry Software in Europe PR Newswire LONDON, October 14, 2016 LONDON...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す